Why the study?
Does epidural ropivacaine 0.75% provide safe and stable anesthesia for cesarean section in a parturient with severe pulmonary hypertension?
Does epidural ropivacaine 0.75% provide safe and stable anesthesia for cesarean section in a parturient with severe pulmonary hypertension?
Epidural ropivacaine 0.75% may be a safe and effective anesthetic option for cesarean section in patients with severe primary pulmonary hypertension.
Answers are grounded in this paper and cite their sources.
May warrant consideration of titrated epidural ropivacaine for cesarean in severe pulmonary hypertension; leaves open prospective validation.
Pregnancy and delivery are a potentially lethal combination in a patient with primary pulmonary hypertension. There are controversies regarding mode of delivery. Cesarean section is considered to be associated with extensive perioperative risks. We report on a parturient with severe pulmonary hypertension who underwent a succesful semiemergent cesarean section on vital indication. Vaginal delivery was excluded since her cervix was too immature for succesful induction. This is the first reported case of its kind to receive an epidural anesthesia with ropivacaine with its potential advantage of a low cardiac toxicity. The epidural was slowly and carefully titrated to give a stable anesthesia with good quality.
No takes yet. Share an insight, caveat, or question.
Olofsson et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: